Clinical Trials

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT02387216 2021-10-12

SHERLOC

Phase 2 Terminated

153 enrolled 19 charts

Fibromatosis, Gingival, 2, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT01577654 2021-04-01

TARGET

203 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00515411 2019-12-10

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

111 enrolled 11 charts

Adenocarcinoma, Stomach Neoplasms

NCT01504256 2018-01-23

CatuNeo

42 enrolled

Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT01472029 2017-06-19

HerFLOT

53 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT01129206 2016-06-01

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

6 enrolled 6 charts

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Neoplasms

NCT01932580 2015-10-27

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

10 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma

NCT00813072 2012-03-02

Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

135 enrolled

Adenocarcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT00242918 2012-02-07

Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer

29 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT00908336 2009-05-25

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Phase 2 Unknown

70 enrolled

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00669370 2008-04-30

GAST-TaxXel

Phase 2 Unknown

50 enrolled